“Project BioShield” Offers Funding Source For Biotech, McClellan Tells BIO
Executive Summary
The biotechnology industry should embrace Project BioShield as a guaranteed market for innovative counter-terrorism technologies, Commissioner McClellan said during the Biotechnology Industry Organization CEO and investor conference Feb. 27 in New York
You may also be interested in...
BIO Gets Pep Talk From Commander-In-Chief; Is Boom-And-Bust Cycle Over?
The recent rebound in the biotechnology sector is "for real," FDA Commissioner McClellan declared during the Biotechnology Industry Organization annual meeting in Washington, D.C. June 23
BIO Gets Pep Talk From Commander-In-Chief; Is Boom-And-Bust Cycle Over?
The recent rebound in the biotechnology sector is "for real," FDA Commissioner McClellan declared during the Biotechnology Industry Organization annual meeting in Washington, D.C. June 23
“Project BioShield” Model Could Apply More Broadly, FDA Commissioner Says
"Project BioShield" offers a model that policymakers should consider to encourage research in infectious diseases, FDA Commissioner McClellan told the Commonwealth Club in San Francisco June 9